Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Thompson Street Capital Partners (TSCP) is a St. Louis-based private equity firm, founded in 2000, specializing in growth investments in founder-led, middle-market businesses. Its primary sectors of focus include Life Sciences & Healthcare, Software & Technology, and Business & Consumer Services. TSCP provides capital, operational expertise, and strategic support to accelerate growth, often through organic expansion and add-on acquisitions. The firm emphasizes long-term value creation and market leadership, having managed over $1.5 billion in equity across multiple funds, with its fifth fund recently closing at $1.15 billion. While investing in healthcare-related companies such as those in orthobiologics, healthcare IT, and revenue cycle management, TSCP itself does not develop drugs, biologics, or devices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Thompson Street Capital Partners.